Prot #AV001‐004: A Randomized, Double‐blind, Placebo‐controlled, Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV‐001 Injection in Patients Hospitalized with Pneumonia Due To COVID‐19 or Other Respiratory Infec

Project: Research project

Project Details

Effective start/end date10/25/2310/25/26


  • Veristat, LLC (Prot #AV001-004 // Prot #AV001-004)
  • Vasomune Therapeutics, Inc. (Prot #AV001-004 // Prot #AV001-004)